These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 15837265
1. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. Capone ML, Sciulli MG, Tacconelli S, Grana M, Ricciotti E, Renda G, Di Gregorio P, Merciaro G, Patrignani P. J Am Coll Cardiol; 2005 Apr 19; 45(8):1295-301. PubMed ID: 15837265 [Abstract] [Full Text] [Related]
2. Human pharmacology of naproxen sodium. Capone ML, Tacconelli S, Sciulli MG, Anzellotti P, Di Francesco L, Merciaro G, Di Gregorio P, Patrignani P. J Pharmacol Exp Ther; 2007 Aug 19; 322(2):453-60. PubMed ID: 17473175 [Abstract] [Full Text] [Related]
3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Capone ML, Tacconelli S, Sciulli MG, Grana M, Ricciotti E, Minuz P, Di Gregorio P, Merciaro G, Patrono C, Patrignani P. Circulation; 2004 Mar 30; 109(12):1468-71. PubMed ID: 15037526 [Abstract] [Full Text] [Related]
8. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. Greenberg HE, Gottesdiener K, Huntington M, Wong P, Larson P, Wildonger L, Gillen L, Dorval E, Waldman SA. J Clin Pharmacol; 2000 Dec 30; 40(12 Pt 2):1509-15. PubMed ID: 11185674 [Abstract] [Full Text] [Related]
10. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis. Gengo FM, Rubin L, Robson M, Rainka M, Gengo MF, Mager DE, Bates V. J Clin Pharmacol; 2008 Jan 30; 48(1):117-22. PubMed ID: 18094224 [Abstract] [Full Text] [Related]
11. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, Davì G, Patrono C. J Am Coll Cardiol; 2009 Feb 24; 53(8):667-77. PubMed ID: 19232899 [Abstract] [Full Text] [Related]
16. Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men. Tuleja E, Mejza F, Cmiel A, Szczeklik A. Arterioscler Thromb Vasc Biol; 2003 Jun 01; 23(6):1111-5. PubMed ID: 12730088 [Abstract] [Full Text] [Related]
17. The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa. Treiber G, Wex T, Link A, Vieth M, Laufer S, Malfertheiner P. Aliment Pharmacol Ther; 2006 Jan 01; 23(1):155-67. PubMed ID: 16393293 [Abstract] [Full Text] [Related]